TriangleDecitabine + FLAG-Ida and Total-Body… (NCT06928662)
Decitabine + FLAG-Ida and Total-Body Irradiation trial for Acute Myeloid Leukemia and Other Myeloid Malignancies (NCT06928662). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with acute myeloid leukemia, myelodysplastic syndrome or chronic myelomonocytic leukemia that is at high risk of coming back.
The idea: add decitabine to the preparation for a donor stem cell transplant. Patients receive decitabine with FLAG-Ida chemotherapy and total body irradiation, then donor stem cells. Donors give stem cells by apheresis.
This phase 1 and 2 study first finds a safe decitabine dose, and plans 36 patients. At Fred Hutchinson Cancer Center in Seattle, Naveed Ali leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.